Northeast Pharmaceutical Group Company Overview
- Year Founded
-
1946
- Status
-
Public
- Employees
-
5,727
- Stock Symbol
-
000597
- Investments
-
1
- Share Price
-
$0.60
- (As of Friday Closing)
Northeast Pharmaceutical Group Company General Information
Description
Northeast Pharmaceutical Group Co Ltd is engaged in the production and distribution of ammonium phosphate, sulfuric acid, cement, compound fertilizer, bromine, raw salt, and diammonium phosphate.
Contact Information
Website
www.nepharm.com.cnCorporate Office
- Number 8, Kunminghu Street
- Economic Technology Development District
- Shenyang, Liaoning 110027
- China
Corporate Office
- Number 8, Kunminghu Street
- Economic Technology Development District
- Shenyang, Liaoning 110027
- China
Northeast Pharmaceutical Group Company Stock Performance
As of 20-Nov-2026, Northeast Pharmaceutical Group Company’s stock price is $0.60. Its current market cap is $863M with 1.43B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.60 | $0.62 | $0.60 - $0.84 | $863M | 1.43B | 12.7M | $0.02 |
Northeast Pharmaceutical Group Company Financials Summary
As of 30-Sep-2026, Northeast Pharmaceutical Group Company has a trailing 12-month revenue of $936M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 688,763 | 789,617 | 654,493 | 797,220 |
| Revenue | 936,085 | 983,805 | 1,045,585 | 1,165,133 |
| EBITDA | 23,888 | 112,056 | 153,549 | 139,403 |
| Net Income | 27,487 | 36,164 | 57,118 | 50,666 |
| Total Assets | 1,954,941 | 1,842,147 | 1,978,902 | 2,154,678 |
| Total Debt | 271,962 | 306,828 | 222,979 | 312,959 |
Northeast Pharmaceutical Group Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Northeast Pharmaceutical Group Company Patents
Northeast Pharmaceutical Group Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026032207-A1 | Humanized antibody targeting tfr1 and use thereof | Pending | 09-Aug-2024 | ||
| JP-2024545136-A | Anti-tfr1 antibody mab11-22.1 conjugate for cancer treatment | Active | 06-Dec-2021 | ||
| AU-2022404416-A1 | Anti-tfr1 antibody mab11-22.1 conjugates for cancer treatment | Pending | 06-Dec-2021 | ||
| EP-4444752-A1 | Anti-tfr1 antibody mab11-22.1 conjugates for cancer treatment | Pending | 06-Dec-2021 | ||
| EP-4444752-A4 | Anti-tfr1 antibody mab11-22.1 conjugates for cancer treatment | Pending | 06-Dec-2021 | A61K40/11 |
Northeast Pharmaceutical Group Company Signals
Northeast Pharmaceutical Group Company Acquisitions (1)
Northeast Pharmaceutical Group Company’s most recent deal was a Merger/Acquisition with DCTY Biotech for . The deal was made on 09-Nov-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| DCTY Biotech | 09-Nov-2024 | Merger/Acquisition | Biotechnology |
Northeast Pharmaceutical Group Company ESG
Risk Overview
Risk Rating
Updated September, 30, 2025
46.18 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,271
Rank
Percentile
Pharmaceuticals
Industry
of 908
Rank
Percentile
Pharmaceuticals
Subindustry
of 406
Rank
Percentile
Northeast Pharmaceutical Group Company FAQs
-
When was Northeast Pharmaceutical Group Company founded?
Northeast Pharmaceutical Group Company was founded in 1946.
-
Where is Northeast Pharmaceutical Group Company headquartered?
Northeast Pharmaceutical Group Company is headquartered in Shenyang, China.
-
What is the size of Northeast Pharmaceutical Group Company?
Northeast Pharmaceutical Group Company has 5,727 total employees.
-
What industry is Northeast Pharmaceutical Group Company in?
Northeast Pharmaceutical Group Company’s primary industry is Pharmaceuticals.
-
Is Northeast Pharmaceutical Group Company a private or public company?
Northeast Pharmaceutical Group Company is a Public company.
-
What is Northeast Pharmaceutical Group Company’s stock symbol?
The ticker symbol for Northeast Pharmaceutical Group Company is 000597.
-
What is the current stock price of Northeast Pharmaceutical Group Company?
As of 20-Nov-2026 the stock price of Northeast Pharmaceutical Group Company is $0.60.
-
What is the current market cap of Northeast Pharmaceutical Group Company?
The current market capitalization of Northeast Pharmaceutical Group Company is $863M.
-
What is Northeast Pharmaceutical Group Company’s current revenue?
The trailing twelve month revenue for Northeast Pharmaceutical Group Company is $936M.
-
What is Northeast Pharmaceutical Group Company’s annual earnings per share (EPS)?
Northeast Pharmaceutical Group Company’s EPS for 12 months was $0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process